Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

• Published in: Frontiers in endocrinology (Lausanne) Vol. 16; p. 1525392
• Main Authors: Wang, Chong, Feng, Ying, Chen, Yu, Lin, Xianhua, Li, Xiangjuan
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2025
• Subjects: Adult; Biomarkers - analysis; Biomarkers - blood; Biomarkers - metabolism; Endocrinology; Female; follicular development; follicular fluid; Follicular Fluid - metabolism; Humans; Inflammation - blood; Inflammation - metabolism; Ovarian Follicle - growth & development; Ovarian Follicle - metabolism; Ovarian Follicle - physiology; ovarian function; Ovarian Reserve - physiology; Ovary - metabolism; Ovary - physiology; Prospective Studies; Proteomics - methods; proximity extension assay; serum; Young Adult; follicular development; proximity extension assay; serum; ovarian function; follicular fluid
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2025.1525392

Many components in follicular fluid (FF), such as peptide hormones, cytokines, and steroids, undergo dynamic changes during folliculogenesis and have important roles in follicular development. Because systemic inflammation has also been found to contribute to diminished ovarian reserve (DOR) in previous studies, do certain serum/FF inflammatory biomarkers affect both follicular development and ovarian function? Serum samples from the menstruation phase (n=26), serum samples from the ovulation phase (n=26), FF samples of mature oocytes (n=26), and FF samples of immature oocytes (n=10) were collected. Olink proteomic proximity extension assay (PEA) technology was used to compare the differentially expressed proteins (DEPs), and patients were divided into two subgroups-the normal ovarian reserve (NOR) group and the DOR group-for further bioinformatics analysis and verification by enzyme-linked immunosorbent assay (ELISA). In total, 16 DEPs were detected between the mature group and the immature group (FF), and 11 DEPs were detected between the ovulation group and the menstruation group (serum). Further subdivision of the ovarian reserve subgroups revealed 22 DEPs in FF and 3 DEPs in serum. Among all four comparisons, only the expression of oncostatin M (OSM) significantly differed. The OSM signaling pathway, the IL-10 anti-inflammatory signaling pathway, and the PI3K-Akt signaling pathway are three notable pathways involved in affecting ovarian reserve capacity according to bioinformatics analysis. In addition, the concentration of estradiol on the hCG day was slightly but positively correlated with OSM ( =0.457, =0.029). A significantly greater level of OSM (5.41 ± 2.65 vs. 3.94 ± 1.23 pg/mL, =0.007) was detected in the serum of NOR patients via ELISA verification, and the sensitivity and specificity of ovarian reserve division were 50.00% and 83.33%, respectively. This study proposed that immunological changes assessed by PEA technology affect ovarian function in humans and that OSM may serve as a potential inflammatory biomarker for ovarian function in serum, thus revealing alterations in FF.